MaxCyte Inc (MXCT) is a Healthcare · Medical Devices company listed on NASDAQ. Price $1.20 (+1.27%), Market cap $0.09B, 52-week low–high $0.68 ~ $2.92.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electropo
Financial statements, price targets, institutional (13F) holdings and related news for MaxCyte Inc are updated in real time on BlackAll Trade.
MaxCyte Inc trades at $1.20 (+1.27%). Real-time quotes and charts are available on BlackAll Trade.
MaxCyte Inc has a market cap of about $0.09B.
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static elec